🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05767151
Recruiting Observational

Chinese DENOVO PD Registry

NCT05767151 · tracked via the Priya Life Science China tracker
Sponsor
Xiangya Hospital of Central South University
Phase
Observational
Started
2021-01-01
Last updated
2023-03-14

Condition(s) studied

Parkinson Disease

Study summary

The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.

Eligibility

Sex
ALL
Min age
30 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Participants were diagnosed by MDS Clinical Diagnostic Criteria for PD 2. Disease duration ≤ 2 years at baseline 3. Hoehn-Yahr stage ≤2 at baseline 4. The age of PD patients ranges from 30 to 75 years old 5. Participants were naive to antiparkinsonian therapy 6. Able to Written informed consent Exclusion Criteria: 1. Participants were diagnosed with parkinsonism-syndrome 2. Participants were treated with antiparkinsonian drugs at baseline 3. Participants with cognitive impairment 4. Unable to Written informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xiangya Hospital of Central South University Changsha Hunan Recruiting

More Xiangya Hospital of Central South University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05767151 on ClinicalTrials.gov ↗ ← All trials in China